NASDAQ:CHRS

Coherus Biosciences Stock Forecast

etoro logo Buy CHRS
*Your capital is at risk
$1.47
-0.0500 (-3.29%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of CHRS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CHRS to Watchlist?
Some Reasons Why To Add CHRS:
  • +84.4% price growth over the last year
  • High gross margin of 60.0%
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Red day on Wednesday for Coherus BioSciences
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 27, 2026 Loss -11.45%

The Coherus BioSciences stock price fell by -3.29% on the last day (Wednesday, 3rd Jun 2026) from $1.52 to $1.47. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 4.11% from a day low at $1.46 to a day high of $1.52. The price has been going up and down for this period, and there has been a -0.68% loss for the last 2 weeks. Volume has increased on the last day by 141 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $1.52 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.42 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.18% during the next 3 months and, with a 90% probability hold a price between $1.33 and $1.81 at the end of this 3-month period.

CHRS Signals & Forecast

There are few to no technical positive signals at the moment. The Coherus BioSciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.59 and $1.71. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -11.45%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Coherus BioSciences stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0600 between high and low, or 4.11%. For the last week, the stock has had daily average volatility of 4.14%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CHRS) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Coherus BioSciences to open at $1.48, and during the day (based on 14 day Average True Range), to move between $1.42 and $1.52, which gives a possible trading interval of +/-$0.0999 (+/-7.04%) up or down from last closing price. If Coherus BioSciences takes out the full calculated possible swing range there will be an estimated 7.04% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.63, some $0.160 (10.88%) from the current price of $1.47, our system finds the risk reward not very attractive.

Is Coherus BioSciences stock A Buy?

Coherus BioSciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.568 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $1.48 ( 0.91%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CHRS Performance

Trading levels for CHRS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.54 4.99%
R2 1.52 3.43%
R1 1.51 2.47%
Price 1.47
S1 1.46 -0.652%
S2 1.45 -1.62%
S3 1.42 -3.17%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.76 19.73%
R2 1.71 16.33%
R1 1.63 10.88%
Price 1.47
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Coherus BioSciences Stock and on which exchange is it traded?
The symbol for Coherus BioSciences is CHRS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Coherus BioSciences Stock?
Coherus BioSciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Coherus BioSciences Stock?
Coherus BioSciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Coherus BioSciences Stock.

What's the current price of Coherus BioSciences Stock?
As of the end of day on the Jun 03, 2026, the price of an Coherus BioSciences (CHRS) share was $1.47.

What is the 52-week high and low for Coherus BioSciences Stock?
The 52-week high for Coherus BioSciences Stock is $2.62 and the 52-week low is $0.710.

What is the market capitalization of Coherus BioSciences Stock?
As of the Jun 03, 2026, the market capitalization of Coherus BioSciences is 179.943M.

When is the next earnings date for Coherus BioSciences?
The upcoming earnings date for Coherus BioSciences is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT COHERUS BIOSCIENCES
Coherus BioSciences
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE